• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Quiz

Article

Dermatology Times' Sunday Crossword: May 11, 2025

Key Takeaways

  • The crossword puzzle integrates recent dermatology news, including treatments, research, and trends, to reinforce professional knowledge.
  • Dermatology Times' Weekly Roundup offers detailed insights into significant dermatology stories and updates from the past week.
SHOW MORE

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Dermatology Times Sunday crossword logo

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the week.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Dermatology Times Sunday crossword

Across

3. Receptor agonist class showing promise in managing psoriasis
6. Skin cancer spotlighted during May awareness initiatives
7. US agency launching AI integration across all centers by mid 2025
9. Key factor in aesthetic dermatology supported by cultural competency
11. Biologic target with potential to reshape AD treatment strategy
12. Topical JAK inhibitor improving HRQoL in chronic hand eczema
13. Media brand acquired by Dermatology Times' parent company to expand beauty coverage
14. Off-label IL-17A inhibitor effective for hidradenitis suppurativa after adalimumab failure

Down

1. Selective ITK inhibitor showing rapid efficacy in phase 1 atopic dermatitis trial
2. JAK inhibitor with cardiovascular risk reduction benefits in AD
4. Ongoing challenge in dermatology patient treatment plans
5. PDE4 inhibitor showing dual-site efficacy in scalp and body psoriasis
8. JAK1 inhibitor with age-linked safety differences in AD treatment
10. (Abbreviation) Dermatology society collaborating with AAD for inclusive clinical visuals

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our May 4, 2025 puzzle: [Across: 3 - melanoma; 5 - OX40; 6 - bempikibart; 8 - hyaluronic; 10 - DecisionDX; 11 - collagen; Down: 1 - guselkumab; 2 - isotretinoin; 4 - photoaging; 7 - sound; 9 - pzcel; 12 - AK]

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.